SS

Sahebrao Shamrao Kadam

Active Director Director DIN 08214900
DIN 08214900 First appointment Sep 2018 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Sahebrao Shamrao Kadam

Data last updated:

Sahebrao Shamrao Kadam is a Director at Astire Pharmaceutical Private Limited (since 2018). The company operates in Pharma.

DIN 08214900
Primary Designation Director
Industry Pharma
First Appointment 04 Sep 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Sep 20182018Active

Directorship timeline

Open interactive timeline →
Astire Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sahebrao Shamrao Kadam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sahebrao Shamrao Kadam

Sahebrao Shamrao Kadam currently holds 1 directorship: Astire Pharmaceutical Private Limited (Director, since 04 Sep 2018).

Sahebrao Shamrao Kadam was first appointed on 04 Sep 2018 as Director at Astire Pharmaceutical Private Limited.

The current boards of Sahebrao Shamrao Kadam's companies include Bhausaheb Kashinath Mitke (Astire Pharmaceutical Private Limited), Nandkumar Baburao Gogade (Astire Pharmaceutical Private Limited), Shashikant Shivajirao Surwase (Astire Pharmaceutical Private Limited), Yogita Santosh Khadangle (Astire Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available